Daiichi Sankyo Company, Limited (TYO: 4568)
Japan
· Delayed Price · Currency is JPY
4,450.00
+33.00 (0.75%)
Jan 21, 2025, 3:30 PM JST
Daiichi Sankyo Company Employees
Daiichi Sankyo Company had 18,726 employees as of March 31, 2024. The number of employees increased by 1,291 or 7.40% compared to the previous year.
Employees
18,726
Change (1Y)
1,291
Growth (1Y)
7.40%
Revenue / Employee
93.88M JPY
Profits / Employee
13.37M JPY
Market Cap
8,361.23B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 7,604 |
HOYA Corporation | 35,702 |
Takeda Pharmaceutical Company | 49,281 |
Otsuka Holdings | 34,388 |
Astellas Pharma | 14,754 |
Olympus | 28,838 |
Shionogi & | 4,959 |
Sysmex | 10,042 |
Daiichi Sankyo Company News
- 4 days ago - DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer - Benzinga
- 4 days ago - DATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer - Benzinga
- 4 days ago - AstraZeneca, Daiichi Sankyo antibody-drug conjugate Dato-DXd gains FDA nod - Seeking Alpha
- 7 days ago - AstraZeneca (AZN) and Daiichi Sankyo's ADC Drug Gains Priority Review by FDA - GuruFocus
- 8 days ago - Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH - Business Wire
- 11 days ago - High Expectations And Data Disappointments Have Driven Daiichi Sankyo Lower - Seeking Alpha
- 25 days ago - Daiichi Sankyo gets Japanese approval for Datroway - Seeking Alpha
- 4 weeks ago - Astra, Daiichi Withdraw EU Application for Lung Cancer Drug - BNN Bloomberg